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Regular drug use can lead to addiction, but not everyone who
takes drugs makes this transition. How exactly drugs of abuse
interact with individual vulnerability is not fully understood, nor is
it clear how individuals defy the risks associated with drugs or
addiction vulnerability. We used resting-state functional MRI
(fMRI) in 162 participants to characterize risk- and resilience-
related changes in corticostriatal functional circuits in individuals
exposed to stimulant drugs both with and without clinically di-
agnosed drug addiction, siblings of addicted individuals, and con-
trol volunteers. The likelihood of developing addiction, whether
due to familial vulnerability or drug use, was associated with sig-
nificant hypoconnectivity in orbitofrontal and ventromedial pre-
frontal cortical-striatal circuits—pathways critically implicated in
goal-directed decision-making. By contrast, resilience against a di-
agnosis of substance use disorder was associated with hypercon-
nectivity in two networks involving 1) the lateral prefrontal cortex
and medial caudate nucleus and 2) the supplementary motor area,
superior medial frontal cortex, and putamen—brain circuits re-
spectively implicated in top-down inhibitory control and the reg-
ulation of habits. These findings point toward a predisposing
vulnerability in the causation of addiction, related to impaired
goal-directed actions, as well as countervailing resilience systems
implicated in behavioral regulation, and may inform novel strate-
gies for therapeutic and preventative interventions.
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The use of addictive drugs is a growing global public healthproblem. Drug addiction develops with persistent drug use,
and individuals who are vulnerable to developing addiction may
do so as quickly as within their first year of use (1). Improving
our understanding of the brain systems that are implicated in
resilience to developing addiction, or “substance use disorder”
according to the Diagnostic and Statistical Manual DSM-5 (2),
would offer new opportunities for its prevention and treatment,
particularly in young people at risk for addiction.
Over the past decade, a large body of work has elucidated how
addictive drugs affect brain function, specifically that of different
striatal subsystems that have been critically implicated in the
development of addictive behavior (3). Importantly, not every-
one who uses drugs, even highly addictive drugs such as am-
phetamines or cocaine, makes the transition to addiction (1). A
family history of drug addiction has been shown to confer an
eightfold increased risk of developing addiction (4), and this
likely relates to a combination of genetic (5) and environmental
(6) risk factors. However, relatively little is known about factors
that protect people from developing addiction: i.e., confer
resilience. The term “resilience” refers to protective factors that
help individuals to successfully cope with or overcome exposure
to significant risk, adversity, or potentially harmful environments
(7). These factors may include personality traits and attitudes,
supportive environments (8), and neural systems that are more
robust to, or able to compensate for, adverse exposures (9).
Much of the neuroscientific research on resilience has been ex-
amined in adolescence (10), which is a period of heightened
vulnerability and neural plasticity (11). While studies of adoles-
cents are important to inform the development and imple-
mentation of preventative strategies, we also need to understand
how resilience operates in vulnerable adults as the compensatory
mechanisms that have been characterized in adolescents do not
necessarily translate into adulthood. For example, the cognitive
deficits frequently measured in adolescents with a family history
of addiction (12, 13) are not seen in adults with familial risk (14,
15), which may suggest that adults manage to counteract their
vulnerabilities more effectively than adolescents by recruiting
compensatory brain systems (16–18). Understanding how po-
tentially vulnerable adults defy the risk of addiction may inform
the development of more effective treatment strategies for in-
dividuals affected by the disorder.
A more compelling illustration of resilience to drug addiction
is demonstrated by individuals who regularly use highly addictive
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drugs like cocaine but do not succumb to addiction and maintain
successful lives (19). These individuals have been described as
highly intelligent (20), well-educated, affluent, and socially well-
integrated (21). They use drugs in a manner that avoids conflict
with their private and professional commitments (21). These
recreational users are less visible and thus less well-studied than
their addicted counterparts, who already have a diagnosis of
substance use disorder and are generally recruited through re-
ferrals from treatment services. The available evidence, however,
indicates that the recreational users function at a comparable
level to control participants by recruiting compensatory brain
systems, which appears to buffer the impact of their drug use (22,
23). It is thus conceivable that this ability to recruit compensa-
tory brain systems represents a resilience factor to developing
drug addiction. However, to date, very little is known about the
mechanisms by which drugs of abuse interact with addiction
vulnerability.
Alteration of dopamine signaling in the basal ganglia is
thought to be involved in the development of certain substance-
related addictions (24). There is considerable evidence that ad-
diction develops through the progressive engagement of differ-
ent striatal subsystems along a ventral-to-dorsal gradient (25, 26)
via associative learning processes implicated in habit formation.
Habits typically arise when goal-directed behaviors become au-
tonomous of the goal through repetition. Drugs of abuse may
foster this transition, precipitating the development of compul-
sive behavior possibly by nonmutually exclusive mechanisms: 1)
Chronic exposure to drugs of abuse (contrary to natural rewards)
compromises the neural system for goal-directed behavior
(orbitofrontal cortex [OFC] and ventromedial prefrontal cortex
[vmPFC]), thereby biasing decisions toward drug-related rewards
and shifting behavioral control toward the habit system; 2) reg-
ular drug use alters the dopamine system and facilitates the
ventral-to-dorsal striatal transition from goal-directed to habitual
instrumental performance, and 3) chronic drug use weakens
cognitive control—the flexible regulation of behavior between
goal-directed and habitual actions, which intervenes whenever
behavior becomes maladaptive. Drug-induced changes affect
interactions between the inferior lateral prefrontal cortex, an-
terior cingulate cortex, and striatum (27).
We posited that addiction risk and resilience would be asso-
ciated with critical changes in the functioning of these cortico-
striatal systems, and we therefore investigated resting-state
corticostriatal connectivity in individuals with familial risk for
addiction, or those engaging in regular drug use, and the in-
teraction of these factors. As addiction develops in combination
of drug use and predisposing factors, we hypothesized that fa-
milial characteristics (as defined by risk factors shared by family
members) in interaction with drug-related effects are critical for
the transition to addiction in at-risk individuals. We deliberately
focused on stimulant drugs because of their direct effect on the
midbrain dopamine system that modulates corticostriatal function,
resulting in their high addiction liability. We collected resting-state
brain activity in individuals with familial risk of addiction, of whom
half were addicted to stimulant drugs, and the other half were
their unaffected biological siblings. We compared these partici-
pants with individuals with no family history of addiction, of whom
half had a personal history of regular stimulant drug use (but not a
formal diagnosis of addiction), while the other half did not. Our
specific hypotheses were that an increased vulnerability for ad-
diction would be reflected in functional dysconnectivity in fron-
tostriatal pathways implicated in goal-directed behavior and
prefrontal control (28) and that resilience to developing addiction
would be associated with compensatory responses within the goal-
directed system or dorsal-striatal subsystems implicated in habit
regulation (29).
Results
Group characteristics are shown in Table 1. Three of the six
striatal seed regions, the ventromedial caudate (vmCAU), ven-
trolateral putamen (vlPUT), and posterior/dorsolateral putamen
(pdlPUT) revealed significant group differences in resting-state
functional connectivity (RSFC) within distinct anatomical path-
ways (Table 2). The topographies of the identified networks are
consistent with prior work by DiMartino et al. (30) and the
widely described corticostriatal circuitries (31) (Fig. 1).
Vulnerability-Related Functional Dysconnectivity. Familial risk of
addiction was associated with significantly reduced functional
connectivity in frontostriatal pathways between the vmCAU seed
with the rostral anterior cingulate cortex (rACC), medial, though
mainly lateral, OFC, and medial prefrontal cortex (mPFC). These
connections survived cluster-level correction (within the whole
brain) and (for extracted scores) post hoc statistical correction
using a mixed-effect model (β = −0.189, P = 0.045). As shown in
Fig. 2A, the group differences were mainly left-lateralized, and
participants with both familial risk and stimulant use (F+S+)
showed the greatest reduction in RSFC compared with all of the
other groups; participants with familial risk but without stimulant
drug use (F+S−) fell midway between F+S+ and F−S− groups.
Thus, stimulant use interacts with familial risk further to reduce
functional connectivity of cortical (rACC, mPFC, OFC) regions
with the vmCAU.
Stimulant use (i.e., whether in recreational users or diagnosed
stimulant use disorder) was related to hypoconnectivity in two
left-lateralized networks associated with the vmCAU or vlPUT
seeds (Fig. 2B). Compared with nonusers (S−), stimulant users
(S+) showed reduced RSFC between 1) vmCAU and the pos-
terior cingulate gyrus (β = −0.231, P = 0.194) and 2) the vlPUT,
the insula and the supramarginal gyrus, but only the latter sur-
vived post hoc correction (β = −0.299, P = 0.045).
The sibling pairs differed significantly from the other two groups
in terms of education, income, and age of tobacco use onset
(Table 1)—variables that have been considered as preexisting in-
dividual and family characteristics which contribute to chronic drug
use in adulthood (32, 33). When we added these three variables in
our mixed-effect model, the effect of familiality was no longer sig-
nificant (β = −0.114, P = 0.274) while the effect of stimulant use
survived (β = −0.366, P = 0.020), supporting the notion that so-
cioeconomic factors play a critical part in the addiction vulnerability
that family members share.
Interaction of Familial and Stimulant-Related Risks. Significant in-
teraction effects were observed for three of the six seeds:
vmCAU vlPUT, and pdlPUT (Table 2). Individuals who had not
developed addiction despite familial risk (F+S−) or regular
stimulant use (F−S+), showed hyperconnectivity in key networks
compared with those having both (F+S+) or none (F−S−). Both
of these groups (F+S−, F−S+) can be described as “resilient.”
As shown in Fig. 3, both groups showed significant functional
hyperconnectivity between 1) vmCAU and the right inferior
frontal gyrus (IFG) and middle frontal gyrus (Brodmann areas
[BA] 32 and 6) (β = −0.740, P < 0.001), as well as between 2)
pdlPUT and several structures, including the central opercular
cortex, supplementary motor area (SMA), medial superior
frontal cortex, middle cingulate gyrus, and insula cortex (β =
−0.482, P = 0.020). The significant interaction effects related to
the vmCAU and the posterior dlPUT pathways, respectively,
were right-lateralized and significantly correlated with one an-
other in the entire sample (r = 0.31, P < 0.001). However, this
correlation was only evident in individuals who did not use
stimulant drugs (F−S−: r = 0.31, P = 0.030; F+S−: r = 0.37, P =
0.010), and not in stimulant-using participants (F−S+, F+S+).
The lack of this relationship in stimulant-using participants (t =
1.43, P = 0.157) was partly mediated by their pattern of



























compulsive stimulant drug use, as measured by the obsessive-
compulsive drug use scale (OCDUS) (34) (R2 = 0.38, F1,65 =
10.97, P = 0.002), suggesting that 1) compulsive stimulant use
disrupted the interplay between these two regulatory networks
and 2) that the corticostriatal hyperconnectivity in the “resilient”
group contributed to their protection from compulsive drug use.
The inclusion of education, income, and age of tobacco onset as
covariates in the mixed-effect model did not change the signifi-
cance of the results (vmCAU-IFG β = −0.725, P < 0001 and
pdlPUT-SMA β = −0.457, P = 0.033).
Discussion
Changes in corticostriatal circuits have been suggested to un-
derlie both the development and the phenotype of drug addic-
tion, possibly driven by distinct mechanisms. Using seed-based
correlational analysis in corticostriatal systems in four groups
(individuals exposed to stimulant drugs, both with and without
clinically diagnosed drug addiction, the siblings of addicted in-
dividuals, and healthy control volunteers), we identified distinct,
lateralized abnormalities in functional connectivity strength as-
sociated with both increased risk of, and resilience to, developing
stimulant addiction. The risk of developing addiction (whether
due to familial vulnerability or a diagnosis of stimulant use dis-
order) was associated with significant reduction in functional
connectivity (hypoconnectivity) between vmCAU, left OFC, and
vmPFC, regions that have been critically implicated in flexible,
goal-directed, value-based decision-making (35). Resilience
against the risk of developing addiction (either because drug use
was not initiated despite increased genetic or social/environ-
mental risk [unaffected siblings] or regular drug use had not
transitioned into addiction [recreational stimulant users]) was
associated with hyperconnectivity in two regulatory control net-
works: One network involved the right lateral prefrontal cortex
(lPFC) (including the right IFG) and its connections to the
vmCAU. This network is implicated in regulating selected ac-
tions (36) by down-regulating habitual control over behavior
(37). The lPFC should be distinguished from the vmPFC, which
is more associated with the representation of goals (28) and
exhibits hypoconnectivity in participants with familial risk. The
other network involved is the dorsal putamen-SMA, which is
critically implicated in sensorimotor function and the transition
from goal-directed to habitual control over behavior (38, 39).
Resilience thus appears to be associated with hyperconnectivity
between different sectors of the prefrontal cortex and the stria-
tum, presumably maintaining regulation over goal-directed be-
havior and its transition to habitual control.
Risk of Addiction Is Associated with Hypoconnectivity in vmPFC and
Striatal Pathways.As shown in Fig. 2A, familial risk of developing
addiction was associated with a significant reduction in func-
tional connectivity within a vmPFC/OFC-striatal network
encompassing the vmCAU, mPFC, and adjacent medial and
lateral OFC and rACC regions. Hypoconnectivity has generally
been associated with functional decline and cognitive impair-
ment, which, in light of the present findings, points toward a
weakness in the vmPFC, goal-directed system, possibly biasing
behavior toward habitual control. Preclinical studies have shown
that lesions and/or pharmacological manipulations of this path-
way reduce sensitivity to outcome value and facilitate habit for-
mation (40–42). Indeed, reduced task-related activation in this
pathway has repeatedly been reported in drug-addicted adults
during maladaptive decision-making (43–45), which may exem-
plify choices that were not controlled by their consequences. As
hypoconnectivity in the goal-directed system is also seen in un-
affected siblings, it is possible that this functional weakness may
have predated drug-taking, rendering individuals vulnerable to
developing drug addiction upon initiation of stimulant drug use.
Regular stimulant drug use has been shown to correlate with a
reduction of gray matter in the vmPFC (46), suggesting that the
likely preexisting underactivity of this system has been exacer-
bated by chronic stimulant drug use.
The amygdala is also important for modulating both goal-
directed and habitual behavior in addiction, based on several
animal-based studies (47). However, examining the connectivity
of the vmPFC with the amygdala was outside the scope of our
seed-based analysis that was focused solely on the striatum.
Importantly, structures implicated in motivational control over
behavior, such as the nucleus accumbens, did not reveal
Table 1. Descriptive statistics of study participants, with respect to familial risk and stimulant drug use, if not stated otherwise, shown
in means and SD in parentheses




no drug useNo stimulant use Stimulant use No stimulant use Stimulant use
Demographics Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD) F, t, or χ2 P F, t, or χ2 P
Number 48 25 47 42 162 162
Gender, % male 63% 48% 51% 95% 3.7 0.056 7.5 0.006
Handedness, % right 85% 84% 89% 81% 0.01 0.934 0.9 0.352
Ethnicity, white: black: Asian: mixed 48: 0: 0: 0 25: 0: 0 36: 4: 2: 5 32: 3: 2: 5 20.7 0.001 0.8 0.560
Age, y 32.4 (±8.8) 28.4 (±6.7) 32.2 (±8.2) 34.7 (±7.7) 2.7 0.103 0.1 0.797
Body mass index 25.2 (±3.3) 24.8 (±4.2) 26.3 (±5.6) 24.7 (±3.9) 0.6 0.451 2.3 0.127
Duration of formal education, y 12.7 (±1.9) 13.4 (±1.8) 12.2 (±2.0) 11.6 (±1.6) 12.2 0.001 0.3 0.586
Verbal intelligence, NART score 112.6 (±7.9) 116.2 (±5.2) 108.6 (±8.9) 110.4 (±7.1) 14.2 <0.001 1.5 0.216
Childhood adversity, CTQ abuse 17.5 (±5.4) 18.5 (±3.9) 24.3 (±10.8) 27.0 (±11.9) 28.5 <0.001 32 0.077
Community Integration, CIQ-II score 17.9 (±3.2) 18.3 (±2.9) 17.6 (±3.4) 14.4 (±3.9) 9.8 0.002 7.1 0.009
Disposable income, £ per month 663.8 (±938.3) 710.4 (±1149.7) 403.8 (±4.13.5) 415.2 (±667.1) 5.0 0.026 0.02 0.883
Alcohol consumption, AUDIT score 3.2 (±2.3) 5.7 (±1.6) 4.0 (±4.6) 11.3 (±10.9) 7.0 0.009 23.7 <0.001
Tobacco, % never/current/past 43/15/42 12/72/16 4/58/38 2/93/5 36.8 <0.001 36.9 <0.001
Cannabis, % never/current/past 79/0/21 0/44/56 26/17/57 0/69/31 30.3 <0.001 70.1 <0.001
Age of onset tobacco use, y 16.2 (±2.8) 16.1 (±4.0) 14.5 (±2.1) 13.1 (±3.0) 19.6 <0.001 2.8 0.094
Age of onset cannabis use, y 17.9 (±4.2) 16.6 (±2.4) 17.8 (±4.3) 15.0 (±2.8) 0.8 0.367 10.7 <0.001
Age of onset stimulant drug use, y – 19.0 (±2.7) – 16.4 (±2.5) 4.1 <0.001
The term “stimulant use” does not reflect severity and includes both recreational and addictive use. Verbal intelligence estimated by the National Adult
Reading Test (NART), childhood adversity assessed by the abuse score of the Childhood Trauma Questionnaire (CTQ), community integration was evaluated
from the Community Integration Questionnaire Version 2 (CIQ-II), and alcohol consumption assessed by the Alcohol Use Disorders Identification Test (AUDIT).


































abnormalities in functional connectivity. This is consistent with
previous research showing normal activation in the ventral
striatum during reward anticipation in stimulant-addicted adults
(48, 49) and their unaffected siblings (17). Our data thus further
confirm the notion that addiction vulnerability is reflected more
by dysconnectivity in the network that underlies deliberate action
selection rather than the motivational priming of actions.
Stimulant Use Is Associated with Hypoconnectivity between Ventral
Putamen and Insula. We also found that regular use of stimulant
drugs was associated with reduced functional connectivity be-
tween the vlPUT, insula (both anterior and posterior parts), and
the supramarginal gyrus (Fig. 2B), a network associated with
emotional awareness (50) and habituation to either pleasant (51)
or painful stimuli (52). Hypoconnectivity in this network has
previously been reported in cocaine-addicted adults with a high
risk for relapse (53). In light of cocaine’s ability to acutely in-
crease activity in this network (54, 55), the reduced functional
coupling in regular stimulant drug users might reflect tolerance
to the effects of the drug. Reduced functional connectivity be-
tween the vlPUT and the insula further supports the notion of
compromised interoception in stimulant addiction (56, 57),
which may impair intuitive decision-making (58). As bodily
feedback has been shown to influence cognitive–affective pro-
cesses (59) and guide individuals’ choices (60, 61), it could be
speculated that reduced functional connectivity in this pathway
may in part account for the lack of avoidance responses to
aversive events (62, 63) frequently observed in chronic stimulant
users and may contribute to the development of compulsive
drug-seeking.
Resilience Against Addiction Is Associated with Hyperconnectivity in
Corticostriatal Pathways. Hyperconnectivity in two regulatory
control pathways in resilient individuals may seem paradoxical as
these individuals do not meet the criteria for addiction and
typically perform within the normal range. However, hyper-
connectivity at rest is not thought to be associated with dys-
function but instead to reflect compensatory efforts to meet
increased functional demands (64–66). This may explain why
unaffected first-degree relatives of addicted individuals show
significant overactivation in the lPFC network during tasks of
response inhibition (16, 67) and interference control (22, 68) for
which hyperconnectivity at rest may be enabling. In this study,
addicted individuals (F+S+), whose reduced activation in this
network has previously been associated with widespread im-
pairments in a range of executive control tasks (69), show equally
Table 2. Regions showing significant functional resting-state connectivity with the striatal
seeds depicted in Fig. 1A











OFC, mPFC, rostral ACC, 143 −9, 39, −9 11
mPFC 21 9, 36, −15 11
mPFC 19 −6, 66, 6 10
Stimulant
Use
PCC 10 −3, −24, 42 23, 31





Insula 126 −39, 6, −3 48
Supramarginal gyrus 79 57, −30, 42 40
Supramarginal gyrus 57 −57, −42, 36 39, 40




Interaction Central opercular cortex 35 57, 3, 9 48, 6
Superior medial frontal cortex, SMA,
cingulate gyrus (middle), insula
10 0, 12, 45 6, 32
6 15, 9, 39 32, 24
3 39, 6, 6 13
ACC, anterior cingulate cortex; IFG, inferior frontal gyrus; mPFC, medial prefrontal cortex; OFC, medial and
lateral parts of the orbitofrontal cortex; PCC, posterior cingulate cortex; SMA, supplementary motor area.
Fig. 1. (A) Illustration of the six striatal regions of interest in the analysis. These seed regions were first described by DiMartino et al. (30) using anatomical
labels, but we decided to use functionally relevant terms to make them comparable with the contemporary literature. Ventral striatum (Nucleus accumbens),
ventral striatum inferior; Ventromedial caudate, ventral striatum superior; Dorsomedial caudate, dorsal caudate; Dorsolateral putamen, posterior, dorsal-
caudal putamen; Ventrolateral putamen, ventro-rostral putamen; Dorsolateral putamen, anterior, dorsal-rostral putamen. (B) Schematic illustration of the
key structures within corticostriatal pathways, as previously described (104).



























strong resting-state connectivity in these networks as their non-
drug using peers (F−S−). This may suggest that their regulatory
networks are already at maximal capacity compensating for the
executive control deficits typically seen in addiction (27). Likewise,
the connectivity strength of the putamen-sensorimotor-cortical cir-
cuit was not measurably different between addicted individuals and
control volunteers. This may seem surprising in light of prior evi-
dence suggesting that stimulant-addicted individuals rely on bi-
lateral recruitment of the putamen-sensorimotor-cortical pathway
during simple sensorimotor task performance while, for nondrug
using controls, contralateral recruitment suffices (70). Given that
the putamen-sensorimotor-cortical network is critically implicated
in habit learning, it is tempting to speculate whether bilateral re-
cruitment facilitates the development of pathological habits.
Our data suggest that addiction vulnerability is associated with
increased demands on regulatory control systems, to which re-
silient individuals respond with hyperconnectivity. Compromised
control is a hallmark of addiction, and this may not be solely
reflected in the connectivity strength of the goal-directed and
habit system, but by their interactions. Our data suggest that
regular stimulant drug use disrupts the coupling between these
two regulatory networks, and the degree of this disruption is partly
determined by the severity of compulsive drug use, as measured by
the OCDUS scale. Conceivably, hyperconnectivity of these two
circuitries in the nonaddicted stimulant drug users might prevent
their drug use from developing into a compulsive habit.
A second “top-down” system exerting inhibitory control over
goal-directed actions between the dorsal anterior cingulate and
the vlPUT (68) was also shown to be hyperconnected in resilient
individuals (Table 2), but this effect did not survive post hoc
correction. This is noteworthy because the dorsal anterior cin-
gulate has been termed an automatic alarm system (71), in
support of habit regulation (72, 73), which would support the
notion of resilience being associated with increased strength of
regulation over both goal-directed and habitual behaviors.
Strengths, Weaknesses, and Implications. Examining functional
connectivity within corticostriatal networks across individuals
with and without familial risk and stimulant drug use offers a
unique opportunity for delineating differences in network func-
tion that may underlie vulnerability and resilience to addiction.
By including groups in the study that are understudied in ad-
diction, such as individuals with a family history of addiction and
recreational drug users, we provide a different perspective on the
current addiction literature (74). Most striking is the observation
that we did not find differences between the groups in networks
associated with the nucleus accumbens, which modulates the rein-
forcing effects of stimulant drugs. Instead, differences were only
seen in networks involved in decision-making (goal-directed and
interoceptive decision-making) and behavioral control (anterior
cingulate and prefrontal inhibitory control over striatal outflow).
There are, however, several other factors that we have not
examined, such as genetic influences, drug use severity, or the
concomitant use of other drugs. We therefore want to emphasize
that our main aim was not to ascertain the effects of specific
drugs on brain connectivity, which has already been the subject
of prior work, but to identify the pattern of abnormality associ-
ated with drug addiction and addiction vulnerability more
Fig. 2. (A) Hypoconnectivity between the vmCAU (seed), OFC, mPFC, and rACC is associated with familial vulnerability for developing stimulant drug ad-
diction, as coloured in orange in the brain maps and plotted for each group in the bar chart. Participants with familial risk of addiction showed reduced
functional connectivity strength in this network irrespective of stimulant drug use. (B) Hypoconnectivity between the ventrolateral putamen (seed), insula,
and supramarginal gyrus is associated with regular use of stimulant drugs, as coloured in green in the brain maps and plotted for each group in the bar chart.
Participants who use stimulant drugs show significantly reduced connectivity strength in this network irrespective of their familial risk. Error bars denote
two SEMs.


































generally. We therefore employed a study design in which the
regular use of several drugs was restricted to the group that met
criteria for addiction and less severe drug use was characteristic
of the nonaddicted drug user group. However, all drug-using
participants regularly used stimulant drugs, which directly af-
fect the function of dopaminergic striatal pathways.
We acknowledge that a major limitation is that relevant behav-
ioral data are not available to endorse our conclusions made about
the functioning of the relevant neural circuitries based on our ci-
tation of the extensive functional neuroimaging literature that al-
ready exists for both healthy individuals and stimulant drug users.
Of course, caution should also be used when interpreting these data
because task-induced blood oxygenation level-dependent (BOLD)
activation and spontaneous BOLD activation during resting-state
functional MRI (fMRI) represent different neuronal processes
and are therefore not directly comparable (75).
Although our sample size of 162 was reasonable, the group
sizes were unbalanced, and there was relatedness between the
familiality (F+) but not the control groups (F−). These limita-
tions are largely due to practical reasons of recruitment, but we
have statistically controlled for them and did not include these
covariates in the main model to avoid overfitting. We also ac-
knowledge the limitation that participants with familial risk were
related whereas participants who were using stimulants were not.
We statistically accounted for their relationship by using a
mixed-effect model in which we considered clustering of siblings
within family as a random effect.
Overall exposure to drugs differs between the addicted and
nonaddicted drug users, as would be expected. It also raises the
important question whether nonaddicted users may only be at an
earlier stage in the addiction cycle or represent an entirely dif-
ferent phenotype. We argue for the latter, suggesting that these
nonaddicted drug users show a number of characteristics that
render them less vulnerable to addiction, including less com-
pulsive drug use, later onset of drug use (including stimulant
drug use), higher socioeconomic status, and the absence of both
familial risk and childhood adversity (46). More research is
therefore warranted to test the hypothesis that the characteristics
seen in this nonaddictive phenotype offer protection against the
development of addiction in people who use drugs.
The networks we identified using the striatal seeds are strik-
ingly consistent with previously published research using the
same seeds in healthy individuals (30), and, while the absence of
a significant role of networks involving the nucleus accumbens
was surprising, they otherwise concur with certain contemporary
neural models of addiction (26, 76). Our findings are also con-
sistent with previous resting-state studies in addicted individuals
reporting reduced functional connectivity in prefrontal networks
(77–79), but direct comparisons with prior work are difficult
because of differences in the analyses [i.e., the analysis method
(80, 81) or location of the seeds (82, 83)] and the factorial design
of this study.
Conclusion
This study of functional resting-state connectivity in 162 partic-
ipants examined two key contributors to the neural changes as-
sociated with familial risk, assessed using a group of sibling pairs of
whom one was stimulant-addicted while the other was unaffected,
Fig. 3. Participants who had an increased risk for addiction, either due to stimulant drug use or a family history of addiction, showed increased functional
connectivity in two networks compared to individuals who have such risks and developed addiction, or who do not have these risks and do not use stimulant
drugs: (A) Increased functional connectivity in the goal-directed, inhibitory control network: vmCAU (seed), inferior frontal and middle frontal gyrus, as
coloured in orange in the brain maps and plotted for each group in the bar chart, and (B) habitual control network: dorsolateral putamen (seed), central
opercular cortex, superior medial frontal, SMA, middle cingulate gyrus, and insula, as coloured in blue in the brain maps and plotted for each group in the bar
chart. Error bars denote two SEMs.



























and stimulant drug use, assessed not only in Diagnostic and Sta-
tistical Manual of Mental Disorders, 4th Edition, Text Revision
(DSM-IV-TR)–diagnosed stimulant-addicted individuals (84), but
also in control participants regularly using stimulants recreation-
ally. This innovative design not only yielded markers of familial
risk and resilience but also revealed their interactions. Familial
vulnerability for drug addiction is associated with reduced func-
tional connectivity in networks implicated in instrumental learning
and goal-directed decision-making. Stimulant drugs weaken goal-
directed control even further via hypoconnectivity in pathways
implicated in interoception and negative feedback processing,
which may increase the risk of behavior becoming compulsive,
even in the face of adverse consequences. Resilient individuals
counteract the drive to addiction through hyperconnectivity in two
distinct corticostriatal pathways that have been associated with
top-down goal-directed inhibitory and automatic–habitual control
of behavior, respectively. The present study therefore provides
valuable insight into possible interactions between familial risk
and stimulant drug use for the regulation of behavioral control
and potential disruptions that may occur in the development of
addiction, but more research is clearly warranted into the neural
basis of the changes in functional connectivity to inform the de-
velopment of more effective strategies for preventative and ther-
apeutic interventions of addiction.
Materials and Methods
Participants and Procedures. A total of 179 participants were recruited for this
study (full details described elsewhere) (46). Briefly, the sample included 50
sibling pairs and 79 healthy control volunteers. The sibling pairs comprised
full biological siblings of whom one met the DSM-IV-TR (84) criteria for
dependence on cocaine or amphetamines, who have been using stimulant
drugs for an average of 16.3 y (±6.7 SD), while the other had no personal
history of addiction. Of the 79 healthy control volunteers, none had a family
history of addiction, but 27 had been using stimulant drugs regularly for at
least 2 y (on average, 8.0 y [±6.1 SD]) whereas the remaining 52 reported no
prior experience with drugs (including stimulants). The level of stimulant
drug use differed significantly between the two drug-using groups both in
terms of the duration of stimulant drug use as well as the compulsive pat-
tern of use. Addicted individuals had used stimulant drugs for a longer
duration (t = −5.1, P < 0.001) and in a highly compulsive manner (t = −16.0,
p < 0.001), as reflected by the OCDUS score (mean 24.4 [±9.2]) whereas the
nonaddicted users without a family history of addiction did not (mean 1.2
[±1.7]). Exclusion criteria were a lifetime history of a psychiatric, neurolog-
ical, or neurodevelopmental disorder, traumatic head injury, and stimulant
use for medical reasons.
All participants followed the same protocol, as described elsewhere (46).
They consented in writing before undergoing medical review and psychiatric
screening, which involved a psychiatric assessment using the Structured
Clinical Interview for DSM-IV-TR (85), ascertainment of family history of
addiction by a semistructured interview, evaluation of childhood adversity
(common in families affected by addiction) (86) using the Childhood Trauma
Questionnaire (CTQ) (87), and social integration (which may play a role in
resilience) (88, 89) using the Community Integration Questionnaire Version 2
(CIQ-II) (90). Drug and alcohol use was quantified using the Drug Abuse
Screening Test (DAST-20) (91) and the Alcohol Use Disorders Identification
Test (AUDIT) (92), both of which have demonstrated sensitivity in nonclinical
populations. All stimulant drug-using participants completed the OCDUS
(34) to assess the degree of how compulsively they used the drug. All
addicted individuals (except two) provided a stimulant-positive urine sam-
ple; urine samples provided by all other participants were negative. The
study protocol was approved by the National Research Ethics Committee
(NREC08/H0308/310) and written informed consent was obtained from all
participants before study enrollment.
Acquisition and Preprocessing of Neuroimaging Data. All participants un-
derwent magnetic resonance brain scans at the Wolfson Brain Imaging
Centre, University of Cambridge, United Kingdom, using a Siemens TIM-Trio
3T system with an eight-channel radio frequency head coil array. Partici-
pants were instructed to keep their eyes closed, relax, think of nothing
particular, and lie still in the scanner during the resting-state fMRI scan. The
fMRI data including 261 volumes were acquired with a T2*-weighted echo
planar imaging sequence (echo time [TE] = 30 ms, repetition time [TR] =
2,000 ms, flip angle = 78°, within-plane matrix = 64 × 64, field of view [FOV]
= 192 × 192 mm, 32 axial-slices with 3-mm thickness and 0.75-mm interslice
gap). Whole brain T1-weighted structural images were acquired with a
magnetization-prepared rapid acquisition gradient echo sequence (TE = 2.98
ms, TR = 2,300 ms, inversion time [TI] = 900 ms, flip angle = 9°, FOV = 240 ×
256 mm, 176 sagittal-slices of 1-mm thickness, isotropic 1-mm3 voxels). All
scans were screened for abnormal radiological appearance by a specialist in
neuroradiology. Neuroimaging data of five participants were unavailable
and had to be excluded for 12 owing to poor scanning quality, resulting in a
final sample of 162 participants.
Resting-State fMRI Preprocessing. The resting-state fMRI data were pre-
processed using the FMRIB Software Library (FSL) (version 5.0.9, https://fsl.
fmrib.ox.ac.uk/fsl/fslwiki/). The first six volumes were discarded to ensure
longitudinal magnetization reaches a steady state, resulting in 255 volumes
for each participant. We applied motion correction, removed nonbrain
structures and signals related to 10% background noise, performed intensity
normalization with the grand mean = 1,000 and spatial smoothing with a
6-mm full width at half maximum Gaussian Kernel (using FSL’s SUSAN). Head
motion was evaluated by framewise displacement (FD) (93, 94). Four par-
ticipants were excluded due to excessive head motion (mean FD >0.5 and
over 40% volumes were contaminated with FD >0.5). For the remaining
participants, signal-based motion noise removal was further applied to re-
duce the temporal impact of head motion on resting-state fMRI measures
(95). The independent component analysis automatic removal of motion
artifacts (ICA-AROMA) is an automated approach combining independent
component analysis and machine learning for removing motion artifacts
from fMRI signals, which has been shown effective for reducing confound-
ing effects on resting-state functional connectivity and increasing re-
producibility of resting-state network identification (96). In this study, we
used FSL’s ICA tool (MELODIC) to estimate 100 spatial components for each
participant’s fMRI data, and then ICA-AROMA for motion noise classification
and removal. Voxel-wise regression was then conducted for nuisance vari-
ables, including linear and quadratic trends, average white matter, and ce-
rebrospinal signals of their eroded masks based on individual structural
image segmentation by FSL’s FAST. Subsequently, low frequency non-
neuronal signals were removed from voxel-wise time series by high-pass
filtering (>0.01 Hz) (96). Finally, we denoised and normalized the data
from native to standard space using three-step registration. We first aligned
the mean functional image to participants’ T1 structural image using
boundary-based registration. We then registered the T1 image to the
Montreal Neurological Institute (MNI) 152 structural template using linear
and nonlinear registration. Finally, we wrapped the whole fMRI data into
standard MNI space by combining the above registrations and resampled to
isotropic 3-mm voxels with trilinear interpolation.
Functional Connectivity Analysis and Group Comparisons. The RSFC estimates
were computed using a seed-based approach in this study (97). In light of our
prior work, which identified abnormalities in striatal structure associated
with stimulant drug addiction (46, 98), we selected six bilateral striatal seed
regions that relate to well-defined frontostriatal and corticostriatal net-
works (30), shown in Fig. 1: ventral striatum (nucleus accumbens: ±9,9,−8),
vmCAU (±10,15,0), dorsomedial caudate (dmCAU) (±13,15,9), pdlPUT
(±28,1,3), dlPUT (±25,8,6), and vlPUT (±20,12,−3). We generated the seeds
with a 3.5-mm-radius spherical regions of interest (MNI coordinates de-
scribed by ref. 30). The average preprocessed fMRI time series were
extracted for each seed and then regressed against other voxels’ time series
over the whole brain (using FSL’s FSL_GLM with time series normalized to
the unit SD beforehand), which produced a statistical parametric map in
terms of Pearson’s correlation—RSFC-r map. The Fisher’s r-to-z trans-
formation was conducted, resulting in an RSFC-z map for each seed and each
participant, as the final RSFC outcome measure.
Second-Level Statistical Analysis. To test the effects of stimulant use and
familiality as well as their interaction on RSFC, RSFC-z maps were entered into
the two factorial analysis of covariance (ANCOVA) model as previously de-
scribed (17) to assess main effects of familiality and stimulant use as well as
their interaction on the functional connectivity network of striatal subre-
gions. As stimulant drugs have been shown to affect men and women dif-
ferentially (99), we controlled for gender as the covariate of no interest. As
differential effects have to the best of our knowledge not been found with
respect to ethnicity, we did not control for it. The design matrix was gen-
erated by FSL’s GLM tool, with four group label columns and one column of
demeaned scores for the gender. Nonparametric testing was employed to
identify significant clusters related to effects of interest by FSL’s RANDOMIZE


































with 5,000 permutations andmulticomparison-corrected threshold (i.e., threshold-
free cluster enhancement corrected P < 0.05) (100).
The significant mean cluster RSFC-z values (mean corticostriatal connec-
tivity) identified in the main and interaction effects from the neuroimaging
data were imported into Mplus software (101) and analyzed separately us-
ing mixed-effect models with the following variables as covariates to control
for differences in drug-taking experiences: severity of stimulant use (OCDUS
score) (34), duration of stimulant use (years), alcohol consumption (AUDIT
score) (92), tobacco use (past/present), and cannabis use (past/present). As
the family environment presents a risk factor for addiction (102), we con-
trolled for the shared upbringing of the sibling pairs by assigning siblings
pairs the same family identification number and including it as a random
effect in the mixed-effect model. This two-step approach to the inclusion of
covariates was taken to avoid overfitting in the neuroimaging model.
Demographic and questionnaire data were examined with SPSS (v22, IBM)
using a two-way analysis of covariance (ANCOVA) model with the two
between-subject factors: “familial risk” (familiality, nonfamiliality) and
“stimulant use” (present, absent) (17). Both were included in the same sta-
tistical model to concurrently investigate their distinct and interaction ef-
fects, while mitigating Type I error. In light of the gender-specific responses
to cocaine (103), and that stimulant-using participants are predominantly
male, gender was included as a covariate in all analyses. We also applied
mediation analysis using the process software tool (v2.13; afhayes.com/
index.html) implemented in SPSS to examine the impact of stimulant-related
compulsivity (OCDUS) on the regulatory balance between the identified
inhibitory and habitual control RSFC networks. The χ2 or Fisher’s exact tests
were used for the analysis of categorical data. All statistical tests were two-
tailed, and a significance level was set at 0.05.
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